Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.
The Supreme Court has ruled that tax classification must be determined by a product’s physical form at the point of sale, not by how it may ultimately be used. In a significant setback for the revenue department, the court dismissed appeals seeking to tax Cadila Healthcare’s GRD Powder and GRD Mix as non-alcoholic beverages at 10%.
Healthcare is moving beyond incremental digitisation into a broader technology-led reinvention, with sensors, wearables, 3D-printed skin, reconstructed organs and AI-enabled clinical trials reshaping how care is delivered and financed. The shift is creating fresh opportunities across medtech, biotech and digital health, while also raising the bar for regulation, validation and long-term commercial execution.
A large-scale patient-zero drill involving actors with makeup and simulated symptoms tested the readiness of 73 healthcare facilities and found that 40% failed to respond adequately. The exercise underscores persistent weaknesses in triage, infection-control protocols, and frontline coordination at a time when hospitals remain central to pandemic preparedness and operational resilience.
A new wave of medical technology is moving from research labs into commercial markets, with wearables, 3D-printed tissue, reconstructed organs and AI-enabled clinical trials reshaping how care is delivered and financed. For investors, the shift signals a broader re-rating of healthcare innovation, where data-rich devices and personalized medicine could define the next IPO and growth cycle.
A large-scale patient-zero drill involving actors with makeup and simulated symptoms tested the readiness of 73 healthcare facilities and found that 40% failed to respond adequately. The exercise underscores persistent weaknesses in triage, infection control, and frontline coordination at a time when health systems remain under pressure from cyber, cloud, and supply-chain dependencies.
A new wave of healthcare technology is moving from the lab to the market, with sensors, wearables, 3D-printed skin, reconstructed organs and AI-enabled trial design reshaping how medicine is developed and delivered. The shift is drawing investor attention across markets and IPO pipelines as the sector moves toward more personalized, preventive and digitally monitored care.
Linux Laboratories has secured $70 million in fresh funding from ChrysCapital and Tata Capital Healthcare Fund, marking a significant vote of confidence in India’s pharmaceutical manufacturing and specialty healthcare ecosystem. The company said it will deploy the capital to deepen its presence in core specialties, enter new therapeutic areas, and expand manufacturing capacity as it scales for the next phase of growth.
Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.
Entities frequently referenced alongside Cadila Healthcare: